Physiologic regulation of the epithelial sodium channel by phosphatidylinositides

Oleh Pochynyuk, Vladislav Bugaj, James D Stockand

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Purpose of review Epithelial sodium channel (ENaC) activity is limiting for sodium reabsorption in the distal nephron. Humans regulate blood pressure by fine-tuning sodium balance through control of ENaC. ENaC dysfunction causes some hypertensive and renal salt wasting diseases. Thus, it is critical to understand the cellular mechanisms controlling ENaC activity. Recent findings ENaC is sensitive to phosphatidylinositol 4,5-bisphosphate (PIP2), the target of phospholipase C-mediated metabolism, and phosphatidylinositiol 3,4,5-trisphosphate (PIP3), the product of phosphatidylinositide 3-OH kinase (PI3-K). PIP2 is permissive for ENaC gating possibly interacting directly with the channel. Activation of distal nephron P2Y receptors tempers ENaC activity by promoting PIP2 metabolism. This is important because gene deletion of P2Y2 receptors causes hypertension associated with hyperactive ENaC. Aldosterone, the final hormone in a negative-feedback cascade activated by decreases in blood pressure, increases ENaC activity. PIP3 sits at a critical bifurcation in the aldosterone-signaling cascade, increasing ENaC open probability and number. PIP3-effectors mediate increases in ENaC number by suppressing channel retrieval. PIP3 binds ENaC, at a site distinct from that important to PIP2 regulation, to modulate directly open probability. Phosphoinositides play key roles in physiologic control of ENaC and perhaps dysregulation plays a role in disease associated with abnormal renal sodium handling.

Original languageEnglish (US)
Pages (from-to)533-540
Number of pages8
JournalCurrent Opinion in Nephrology and Hypertension
Volume17
Issue number5
DOIs
StatePublished - Sep 2008

Fingerprint

Epithelial Sodium Channels
Sodium
Nephrons
Phosphatidylinositols
Aldosterone
Purinergic P2Y2 Receptors
Wasting Syndrome
Blood Pressure
Kidney
Gene Deletion
Type C Phospholipases
Phosphotransferases
Salts
Hormones
Hypertension

Keywords

  • Aldosterone
  • Hypertension
  • Phosphatidylinositide 3-OH kinase
  • Phospholipase C
  • Purinergic receptor

ASJC Scopus subject areas

  • Nephrology
  • Internal Medicine

Cite this

Physiologic regulation of the epithelial sodium channel by phosphatidylinositides. / Pochynyuk, Oleh; Bugaj, Vladislav; Stockand, James D.

In: Current Opinion in Nephrology and Hypertension, Vol. 17, No. 5, 09.2008, p. 533-540.

Research output: Contribution to journalArticle

@article{88d29d2d4b0b4cadaeedf6cce437bb26,
title = "Physiologic regulation of the epithelial sodium channel by phosphatidylinositides",
abstract = "Purpose of review Epithelial sodium channel (ENaC) activity is limiting for sodium reabsorption in the distal nephron. Humans regulate blood pressure by fine-tuning sodium balance through control of ENaC. ENaC dysfunction causes some hypertensive and renal salt wasting diseases. Thus, it is critical to understand the cellular mechanisms controlling ENaC activity. Recent findings ENaC is sensitive to phosphatidylinositol 4,5-bisphosphate (PIP2), the target of phospholipase C-mediated metabolism, and phosphatidylinositiol 3,4,5-trisphosphate (PIP3), the product of phosphatidylinositide 3-OH kinase (PI3-K). PIP2 is permissive for ENaC gating possibly interacting directly with the channel. Activation of distal nephron P2Y receptors tempers ENaC activity by promoting PIP2 metabolism. This is important because gene deletion of P2Y2 receptors causes hypertension associated with hyperactive ENaC. Aldosterone, the final hormone in a negative-feedback cascade activated by decreases in blood pressure, increases ENaC activity. PIP3 sits at a critical bifurcation in the aldosterone-signaling cascade, increasing ENaC open probability and number. PIP3-effectors mediate increases in ENaC number by suppressing channel retrieval. PIP3 binds ENaC, at a site distinct from that important to PIP2 regulation, to modulate directly open probability. Phosphoinositides play key roles in physiologic control of ENaC and perhaps dysregulation plays a role in disease associated with abnormal renal sodium handling.",
keywords = "Aldosterone, Hypertension, Phosphatidylinositide 3-OH kinase, Phospholipase C, Purinergic receptor",
author = "Oleh Pochynyuk and Vladislav Bugaj and Stockand, {James D}",
year = "2008",
month = "9",
doi = "10.1097/MNH.0b013e328308fff3",
language = "English (US)",
volume = "17",
pages = "533--540",
journal = "Current Opinion in Nephrology and Hypertension",
issn = "1062-4821",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Physiologic regulation of the epithelial sodium channel by phosphatidylinositides

AU - Pochynyuk, Oleh

AU - Bugaj, Vladislav

AU - Stockand, James D

PY - 2008/9

Y1 - 2008/9

N2 - Purpose of review Epithelial sodium channel (ENaC) activity is limiting for sodium reabsorption in the distal nephron. Humans regulate blood pressure by fine-tuning sodium balance through control of ENaC. ENaC dysfunction causes some hypertensive and renal salt wasting diseases. Thus, it is critical to understand the cellular mechanisms controlling ENaC activity. Recent findings ENaC is sensitive to phosphatidylinositol 4,5-bisphosphate (PIP2), the target of phospholipase C-mediated metabolism, and phosphatidylinositiol 3,4,5-trisphosphate (PIP3), the product of phosphatidylinositide 3-OH kinase (PI3-K). PIP2 is permissive for ENaC gating possibly interacting directly with the channel. Activation of distal nephron P2Y receptors tempers ENaC activity by promoting PIP2 metabolism. This is important because gene deletion of P2Y2 receptors causes hypertension associated with hyperactive ENaC. Aldosterone, the final hormone in a negative-feedback cascade activated by decreases in blood pressure, increases ENaC activity. PIP3 sits at a critical bifurcation in the aldosterone-signaling cascade, increasing ENaC open probability and number. PIP3-effectors mediate increases in ENaC number by suppressing channel retrieval. PIP3 binds ENaC, at a site distinct from that important to PIP2 regulation, to modulate directly open probability. Phosphoinositides play key roles in physiologic control of ENaC and perhaps dysregulation plays a role in disease associated with abnormal renal sodium handling.

AB - Purpose of review Epithelial sodium channel (ENaC) activity is limiting for sodium reabsorption in the distal nephron. Humans regulate blood pressure by fine-tuning sodium balance through control of ENaC. ENaC dysfunction causes some hypertensive and renal salt wasting diseases. Thus, it is critical to understand the cellular mechanisms controlling ENaC activity. Recent findings ENaC is sensitive to phosphatidylinositol 4,5-bisphosphate (PIP2), the target of phospholipase C-mediated metabolism, and phosphatidylinositiol 3,4,5-trisphosphate (PIP3), the product of phosphatidylinositide 3-OH kinase (PI3-K). PIP2 is permissive for ENaC gating possibly interacting directly with the channel. Activation of distal nephron P2Y receptors tempers ENaC activity by promoting PIP2 metabolism. This is important because gene deletion of P2Y2 receptors causes hypertension associated with hyperactive ENaC. Aldosterone, the final hormone in a negative-feedback cascade activated by decreases in blood pressure, increases ENaC activity. PIP3 sits at a critical bifurcation in the aldosterone-signaling cascade, increasing ENaC open probability and number. PIP3-effectors mediate increases in ENaC number by suppressing channel retrieval. PIP3 binds ENaC, at a site distinct from that important to PIP2 regulation, to modulate directly open probability. Phosphoinositides play key roles in physiologic control of ENaC and perhaps dysregulation plays a role in disease associated with abnormal renal sodium handling.

KW - Aldosterone

KW - Hypertension

KW - Phosphatidylinositide 3-OH kinase

KW - Phospholipase C

KW - Purinergic receptor

UR - http://www.scopus.com/inward/record.url?scp=58149335369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149335369&partnerID=8YFLogxK

U2 - 10.1097/MNH.0b013e328308fff3

DO - 10.1097/MNH.0b013e328308fff3

M3 - Article

C2 - 18695396

AN - SCOPUS:58149335369

VL - 17

SP - 533

EP - 540

JO - Current Opinion in Nephrology and Hypertension

JF - Current Opinion in Nephrology and Hypertension

SN - 1062-4821

IS - 5

ER -